Volume 21, Number 6—June 2015
Research
Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 20131
Rania A. Tohme
, Jeannot François, Kathleen Wannemuehler, Preetha Iyengar, Amber Dismer, Paul Adrien, Terri B. Hyde, Barbara J. Marston, Kashmira A. Date, Eric D. Mintz, and Mark A. Katz
, Jeannot François, Kathleen Wannemuehler, Preetha Iyengar, Amber Dismer, Paul Adrien, Terri B. Hyde, Barbara J. Marston, Kashmira A. Date, Eric D. Mintz, and Mark A. Katz
Table 4
Principal reasons for not receiving oral cholera vaccine, by area, Haiti, 2013*
| Reason | Petite Anse, no. ( %) | Cerca Carvajal, no. ( %) |
|---|---|---|
| First dose | ||
| No. who did not receive dose | 348 | 117 |
| Absent during the campaign | 141 (40.5) | 63 (53.8) |
| Did not hear about the vaccination activities | 41 (11.8) | 15 (12.8) |
| Busy/no time | 34 (9.8) | 7 (6.0) |
| Sick during the campaign | 14 (4.0) | 4 (3.4) |
| Didn’t think vaccination was important/necessary | 20 (5.7) | 2 (1.7) |
| Don’t think vaccines are safe/vaccines can harm | 10 (2.9) | 2 (1.7) |
| Vaccines not available | 5 (1.4) | 4 (3.4) |
| Didn’t know when or where to go | 6 (1.7) | 2 (1.7) |
| Clinic closed/vaccinator not there/vaccinator refused to vaccinate | 6 (1.7) | 2 (1.7) |
| Other |
71 (20.4) |
16 (13.7) |
| Second dose† | ||
| No. who did not receive dose | 73 | 54 |
| Absent during second campaign | 21 (28.8) | 13 (24.1) |
| Clinic closed/vaccinator refused to vaccinate | 5 (6.8) | 1 (1.9) |
| Busy/no time | 4 (5.5) | 11 (20.4) |
| Bad experience/ adverse event after first dose | 6 (8.2) | 2 (3.7) |
| Did not know needed a second dose | 3 (4.1) | 1 (1.9) |
| Sick during the campaign | 2 (2.7) | Not reported |
| Didn’t know when or where to go | Not reported | 2 (3.7) |
| Forgot to go | 2 (2.7) | 1 (1.9) |
| Vaccines not available | 1 (1.4) | 7 (13.0) |
| Other | 29 (39.7) | 9 (16.7) |
*Categories are mutually exclusive because respondents were allowed to give only 1 primary reason. Percentages are unweighted for the purpose of description only.
†Of those who received the first dose.
1Results from this study were partially presented at the 49th US–Japan Conference on Cholera and Other Enteric Bacterial Infections; 2015 Jan 14–16; Gainesville, Florida, USA.
Page created: May 15, 2015
Page updated: May 15, 2015
Page reviewed: May 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.